EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Recurrent ischaemia in patients with unstable angina or myocardial infarction without ST-segment elevation treated with eptifibatide predicts mortality and infarction A report from the PURSUIT study



Recurrent ischaemia in patients with unstable angina or myocardial infarction without ST-segment elevation treated with eptifibatide predicts mortality and infarction A report from the PURSUIT study



European Heart Journal 19(ABST SUPPL ): 598




(PDF emailed within 1 workday: $29.90)

Accession: 033119879

Download citation: RISBibTeXText



Related references

Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial. European Heart Journal 23(14): 1102-1111, 2002

Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study. Coronary Artery Disease 19(3): 153-161, 2008

Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction). American Journal of Cardiology 108(10): 1395-1400, 2011

Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction. Critical Pathways in Cardiology 9(2): 55-81, 2010

Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?. American Journal of Cardiology 104(5 Suppl): 4c-8c, 2009

Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography. Research in Cardiovascular Medicine 2(2): 95-98, 2013

Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction. Eurointervention 7(12): 1396-1405, 2012

Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention. Heart 90(8): 902-907, 2004

Prognostic value of the admission electrocardiogram in patients with unstable angina/non-ST-segment elevation myocardial infarction treated with very early revascularization. American Journal of Medicine 117(3): 145-150, 2004

Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. Journal of Electrocardiology 33(2): 127-136, 2000

Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. American Journal of Cardiology 93(10): 1218-1222, 2004

Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction. Lipids in Health and Disease 16(1): 20-20, 2017

Association between platelet receptor occupancy after eptifibatide therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction - An INTEGRITI Integrilin and tenecteplase in acute myocardial infarction substudy. Circulation 110(6): 679-684, August 10, 2004

The impact of platelet count on mortality in unstable angina/non-ST-segment elevation myocardial infarction. American Heart Journal 151(6): 1214.E1-7, 2006

Associations of major bleeding and recurrent myocardial infarction with the incidence and timing of mortality in patients with ST-segment elevation myocardial infarction. European Heart Journal 34(Suppl 1): P1250-P1250, 2013